Saturday, 13 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

ASCO 2008: Cetuximab for metastatic colorectal cancer (mCRC)

ASCO 2008: Cetuximab for metastatic colorectal cancer (mCRC)У вашего броузера проблема в совместимости с HTML5
Professor Carsten Bokemeyer discussing Cetuximab for metastatic colorectal cancer (mCRC).
Опубликовано: 21-01-2010
Теги: gP4 1826 Bokemeyer 320x240

Похожие видео
Introduction: Bevacizumab Versus Cetuximab in Metastatic Colorectal Cancer

Introduction: Bevacizumab Versus Cetuximab in Metastatic Colorectal Cancer04:28

Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli

Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli08:15

Dr. Heinemann on Implications of SIRFLOX Study for mCRC

Dr. Heinemann on Implications of SIRFLOX Study for mCRC01:28

Conducting Extended RAS Testing in Colorectal Cancer

Conducting Extended RAS Testing in Colorectal Cancer07:43

Мой аккаунт

Вход / Log In